Good morning! I couldn’t sleep. Somewhere between 2 and 3 am, something I didn’t know existed clocked me so hard I couldn’t ignore giving it some attention. For years, I’ve been publishing work on essential oil constituents: - the specific molecular components that explain why one chemotype of thyme behaves differently in the body than another - why a particular fraction of rosewood interacts with one receptor and not its neighbor - why biochemical individuality means that the same oil produces different effects in different people This is the work I invested in doing throughout my adult life. It sits at the intersection of pharmacology, neuroscience, epigenetics, and aromatic chemistry, and it highlights, I believe, the most honest answer to questions like what actually helps and what actually changes. And it has, with one exception, struggled to find an audience. The exception is the addiction work. That material has connected with people. They’ve written to me, enrolled in programs, asked harder questions, and kept reading. The constituent-level work on inflammation, on hormone regulation, on neuroplasticity — work I consider equally rigorous and arguably more useful — has not produced the same response. For a long time, I assumed this was a communication problem. I’ve spent considerable energy trying to make the science more accessible, the writing more inviting, the entry points more numerous. Last night I understood it isn’t a communication problem. It’s that the people who responded to the addiction work had already, often through great suffering, been forced to recognize that something essential had gone missing in them. They weren’t looking for a better intervention. They were looking for themselves. The readers who came to the constituent work, by contrast, were still — most of them, most of the time — asking a different question. They were asking, ‘What do I take for this?’ And no amount of refinement in my answers changed the fact that the question itself was the problem.